Archives
Disrupting the c-MYC-G9a-FTH1 Axis in Breast Cancer Subtypes
2026-05-25
The reference study demonstrates that co-targeting BET bromodomain BRD4 and RAC1 disrupts the c-MYC-G9a-FTH1 axis, suppressing growth, stemness, and tumorigenesis in molecular subtypes of breast cancer. These findings highlight the potential of epigenetic intervention and G9a histone methyltransferase inhibition in refining therapeutic strategies and experimental cancer models.
Benzyl-Activated Streptavidin Magnetic Beads: Precision Tool
2026-05-24
Explore how Benzyl-activated Streptavidin Magnetic Beads enable high-fidelity detection of early cell death and streamline complex biochemical assays. This in-depth article offers a scientific perspective on their mechanism, unique hydrophobic activation, and comparative advantages.
ETS1 Regulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model
2026-05-23
This study demonstrates how the transcription factor ETS1 mitigates bronchopulmonary dysplasia (BPD) by orchestrating the SENP2/HSPA8/FUNDC1 axis to inhibit mitochondrial damage-induced autophagy. These findings clarify a sumoylation-dependent mitophagy mechanism, suggesting new avenues for targeted intervention in neonatal lung injury and repair.
L-NMMA Acetate in Periodontal Regeneration: NOS Pathway Insi
2026-05-22
Explore how L-NMMA acetate enables advanced modulation of the nitric oxide pathway in periodontal tissue engineering. This article uniquely examines the intersection of NOS inhibition, stem cell differentiation, and regenerative strategies, offering a fresh perspective for inflammation and dental research.
Ranolazine as an Anti-Ischemic Agent: Protocols and Pitfalls
2026-05-22
Ranolazine delivers unique anti-ischemic and metabolic modulation benefits, making it indispensable for cardiac ischemia and metabolic research. This article translates high-impact workflows and troubleshooting strategies into actionable protocols, bridging advanced metabolic insights with robust experimental design.
Five-Element Nanoparticles Enable Stable Lung-Specific mRNA
2026-05-21
This study introduces five-element nanoparticles (FNPs) using helper-polymer PBAEs and DOTAP to achieve lung-specific mRNA delivery with high stability after lyophilization. The findings offer a new route for mRNA therapeutic development by addressing both delivery efficiency and long-term storage limitations.
Recombinant Human Growth Hormone: Advanced Bench Workflow In
2026-05-21
Recombinant Human Growth Hormone (GH) from APExBIO empowers researchers to precisely dissect growth hormone signaling and chondrocyte proliferation. This guide translates the latest mechanistic discoveries into robust, reproducible protocols and troubleshooting strategies for pituitary growth hormone research.
ALDH2 Inhibition Induces Synthetic Lethality in APC-Deficien
2026-05-20
The reference study demonstrates that ALDH2 inhibition, using Disulfiram, selectively induces apoptosis in APC-deficient colorectal cancer (CRC) cells via the ROS/ASK1/JNK pathway. These findings highlight a promising synthetic lethality-based strategy for overcoming treatment resistance in APC-mutant CRC.
Asiaticoside Blocks TGF-β1-Induced MMT via Nrf2/HO-1 in HPMC
2026-05-20
Zhao et al. provide new mechanistic evidence that asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition (MMT) and oxidative stress in human peritoneal mesothelial cells by activating the Nrf2/HO-1 pathway. These findings clarify potential anti-fibrotic strategies relevant to peritoneal dialysis complications and highlight distinct pathway modulation compared to direct TGF-β receptor inhibition.
N1-Methyl-Pseudouridine-5'-Triphosphate: Reconstructing the
2026-05-19
Explore how N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) is transforming RNA therapeutics by enabling targeted tumor microenvironment modulation and advanced mRNA delivery strategies. Gain new insights beyond standard RNA stability and vaccine development.
LY2109761: Dual TGF-β Receptor Inhibition for Cancer Researc
2026-05-19
LY2109761 is a well-characterized TGF-β receptor type I and II dual inhibitor, demonstrating potent inhibition of Smad2/3 phosphorylation and marked anti-tumor activity in preclinical cancer models. This dossier provides evidence-backed insights, workflow parameters, and practical boundaries for research use.
SAG-Induced Hedgehog Signaling Disrupts Tongue Development i
2026-05-18
This study demonstrates that embryonic overactivation of the Hedgehog pathway via Smoothened Agonist (SAG) at E10.5 impairs tongue morphogenesis in mice by inhibiting cell proliferation and downregulating TGF-β2, resulting in cleft tongue malformations. The findings provide mechanistic insight into how excess pathway stimulation can perturb craniofacial development and serve as a model for dissecting molecular causes of congenital tongue defects.
Bovine Insulin in Cell Senescence Research: Mechanisms & Pro
2026-05-18
Explore the advanced role of bovine insulin as a cell proliferation enhancer and growth factor supplement in senescence and stem cell assays. This article uniquely bridges molecular mechanisms with practical protocols, drawing on the latest Wnt/β-catenin pathway research.
GKT137831: Precision Nox1/Nox4 Inhibition in Redox and Fibro
2026-05-17
Discover how GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor, enables precise control of oxidative stress in advanced fibrosis and vascular remodeling research. This article uniquely explores practical assay design and mechanistic insights beyond standard overviews.
QRICH1-Mediated ER Stress Drives HBV-Induced HMGB1 Secretion
2026-05-16
This study uncovers QRICH1 as a pivotal amplifier of endoplasmic reticulum (ER) stress, enhancing hepatitis B virus (HBV)-driven HMGB1 translocation and secretion in hepatocytes. The findings clarify the mechanistic pathway linking ER stress, QRICH1, and hepatic fibrosis, with implications for targeting fibrogenic responses in chronic liver disease.
609 records 21/41 page Previous Next First page 上5页 2122232425 下5页 Last page